EndoPredict USA

EndoPredict® is a breast cancer recurrence test that accurately identifies patients with early stage breast cancer who can consider forgoing chemotherapy.

[EndoPredict USA @EndoPredictUSA]

Our lifetime commitment to patients does not – and will not – change during this challenging time. Learn how to continue genetic testing without interruption here: https://t.co/mn51AT1VNq #WorkingTogether #MyriadOncology

[EndoPredict USA @EndoPredictUSA]

If your practice is limiting industry access, all Myriad representatives are available via multiple virtual and digital methods. This includes clinical, field, and customer service teams! Learn more: https://t.co/Ul5Uk6Xj82 #WorkingTogether #MyriadOncology

[EndoPredict USA @EndoPredictUSA]

#WorkingTogether

[EndoPredict USA @EndoPredictUSA]

We are here to help! Learn more here: https://t.co/FUNRSxyw6i

[EndoPredict USA @EndoPredictUSA]

You may be wondering how the coronavirus will impact you, your patients, and the ability to receive vital genetic testing information. Myriad Oncology is dedicated to providing genetic testing services without interruption! Learn more: https://t.co/qbbEPFLnro #WorkingTogether

[EndoPredict USA @EndoPredictUSA]

Learn about how Myriad Oncology is working to alleviate obstacles you may be facing here: https://t.co/bypI9Y5SPN #WorkingTogether #MyriadOncology

[EndoPredict USA @EndoPredictUSA]

You may be wondering how the coronavirus will impact you, your patients, and the ability to receive vital genetic testing information. Myriad Oncology is dedicated to providing genetic testing services without interruption! Learn more: https://t.co/72PhW8w0VZ #WorkingTogether

[EndoPredict USA @EndoPredictUSA]

Did you know that Myriad Oncology now has a website? Check it out: https://t.co/XT4UyeyKhp

[EndoPredict USA @EndoPredictUSA]

The new Myriad Oncology website is live! Learn more about what tests we offer and what answers they will provide you and your patients. Explore the website here: https://t.co/MvgMQOLtpe

[EndoPredict USA @EndoPredictUSA]

Myriad Oncology is dedicated to providing answers that help guide cancer treatment decisions and give patients and their families information on hereditary cancer risk. Learn more on the new website: https://t.co/VC6mnGufbf

[EndoPredict USA @EndoPredictUSA]

EndoPredict® gives patients the right answers at the right time. Click here to learn more: https://t.co/LJgFaOXJDB #MiamiBreastCancerConference

[EndoPredict USA @EndoPredictUSA]

EndoPredict® gives patients their early/late distant recurrence risk and individualized absolute chemotherapy benefit. Learn more at booth #44 today at #MiamiBreastCancerConference

[EndoPredict USA @EndoPredictUSA]

EndoPredict®: A breast cancer gene expression profile that is accurate, affordable and accessible. Come by Myriad's booth #44 at #MiamiBreastCancerConference starting tomorrow to learn more.

[EndoPredict USA @EndoPredictUSA]

Join us at the 37th Annual #MiamiBreastCancerConference this week, and learn what EndoPredict® can offer your breast cancer patients. Stop by the Myriad booth #44 to learn more.

[EndoPredict USA @EndoPredictUSA]

EndoPredict® combines tumor biology with pathology for individualized results. Let us show you how at booth 131 at #SABCS19 @MyriadOncology

[EndoPredict USA @EndoPredictUSA]

Attending #SABCS19? Don’t miss today’s poster presentation, Prognostic Value of EndoPredict and Oncotype Recurrence Score According to Patients' Age. Ivana Sestak will present poster P5-06-04 between 5:00-7:00 p.m. @MyriadOncology

[EndoPredict USA @EndoPredictUSA]

Attending #SABCS19? Don’t miss today’s poster presentation, Correlation Between and Molecular Drivers of OncoTypeDx, Prosigna, EndoPredict and BCI. Richard Buus will present poster P3-07-05 between 5:00-7:00 p.m. @myriadgenetics

[EndoPredict USA @EndoPredictUSA]

1 Test with 3 Individualized Clinical Answers. Come see the new report! Stop by Myriad's booth # 113 at #SABCS19 to learn more. @MyriadOncology @myriadgenetics

[EndoPredict USA @EndoPredictUSA]

Binary Result + Stratified Risk = Individualized Care. Learn more about EndoPredict® at booth # 113 at #SABCS19. @MyriadOncology @myriadgenetics

[Myriad Genetics @myriadgenetics]

Myriad leads the way in genetic testing for breast cancer. Learn more about our presentations at #SABCS19: https://t.co/agyMYx4807 #Breastcancer @MyriadMyRisk @EndoPredictUSA